• Роль фолатов в развитии осложнений беременности
ru К содержанию

Роль фолатов в развитии осложнений беременности

HEALTH OF WOMAN.2017.1(117):56–61

Пустотина О. А., Ахмедова А. Э.
КМ-клиник, г. Москва
Опубликовано: «ЭФФЕКТИВНАЯ ФАРМАКОТЕРАПИЯ. Акушерство и гинекология» № 3 (35)/ 2014

В статье рассматриваются биологические функции фолатов в организме, описан метаболизм фолиевой кислоты. Анализируется роль фолиевой кислоты при беременности, а также обсуждаются негативные последствия дефицита и переизбытка фолатов в период гестации. Приведены результаты наблюдения за беременными с полиморфизмом гена метилентетрагидрофолатредуктазы, которые принимали витаминно-минеральный комплекс, содержащий активную форму фолатов – метафолин. Применение комплекса позволило качественно и количественно нормализовать гематологические показатели, а также значительно снизить риск осложнений беременности.

Ключевые слова: метафолин, фолиевая кислота, pregnancy, folic acid, hyperhomocysteinemia, metafolin.

Литература:

1. Pietrzik K., Bailey L., Shane B. Folic acid and L-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics // Clin. Pharmacokinet. 2010. Vol. 49. № 8. P. 535–548. https://doi.org/10.2165/11532990-000000000-00000; PMid:20608755

2. Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes // Mol. Genet. Metab. 2000. Vol. 71. № 1–2. P. 121–138. https://doi.org/10.1006/mgme.2000.3027; PMid:11001804

3. Cunningham F., Leveno K., Bloom S. et al. Williams Obstetrics. 23rd ed. New York: McGraw-Hill, 2009.

4. Crider K.S., Yang T.P., Berry R.J. et al. Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate’s role // Adv. Nutr. 2012. Vol. 3. № 1. P. 21–38. https://doi.org/10.3945/an.111.000992; PMid:22332098 PMCid:PMC3262611

5. Mьller T., Jugel C., Muhlack S. et al. Methyl group-donating vitamins elevate 3-O-methyldopa in patients with Parkinson disease // Clin. Neuropharmacol. 2013. Vol. 36. № 2. P. 52–54. https://doi.org/10.1097/WNF.0b013e318283fa18; PMid:23503547

6. Smith A.D., Kim Y.I., Refsum H. Is folic acid food for everyone? // Am. J. Clin. Nutr. 2008. Vol. 87. № 3. P. 517–533. PMid:18326588

7. Kidd P.M. Alzheimer’s disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention // Altern. Med. Rev. 2008. Vol. 13. № 2. P. 85–115. PMid:18590347

8. Vogel S., Meyer K., Fredriksen A. et al. Serum folate and vitamin B12 concentrations in relation to prostate cancer risk: a Norwegian population-based nested case-control study of 3000 cases and 3000 controls within the JANUS cohort // Int. J. Epidemiol. 2013. Vol. 42. № 1. P. 201–210. https://doi.org/10.1093/ije/dys199; PMid:23508410

9. Duthie S.J. Folat and cancer: how DNA damage, repair and methylation impact on colon carcinogenesis // J. Inherit. Metab. Dis. 2011. Vol. 34. № 1. P. 101–109. https://doi.org/10.1007/s10545-010-9128-0; PMid:20544289

10. Yang I.V., Schwartz D.A. Epigenetic mechanisms and the development of asthma // J. Allergy Clin. Immunol. 2012. Vol. 130. № 6. P. 1243–1255. https://doi.org/10.1016/j.jaci.2012.07.052; PMid:23026498 PMCid:PMC3518374

11. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study // Lancet. 1991. Vol. 338. № 8760. P. 131–137. https://doi.org/10.1016/0140-6736(91)90133-A

12. Ptikin R.M. Folate and neural tube defects // Am. J. Clin. Nutr. 2007. Vol. 85. № 1. P. 285–288.

13. De Wals P., Tairou F., Van Allen M.I. et al. Reduction in neural-tube defects after folic acid fortification in Canada // N. Engl. J. Med. 2007. Vol. 357. № 2. P. 135–142. https://doi.org/10.1056/NEJMoa067103; PMid:17625125

14. Beaudin A.E., Stover P.J. Folate-mediated one-carbon metabolism and neural tube defects: balancing genome synthesis and gene expression // Birth Defects Res. C. Embryo Today. 2007. Vol. 81. № 3. P. 183–203. https://doi.org/10.1002/bdrc.20100; PMid:17963270

15. Greenberg J.A., Bell S.J., Guan Y. et al. Folic acid supplementaion and pregnancy: more than just neural tube defect prevention // Rev. Obstet. Gynecol. 2011. Vol. 4. № 2. P. 52–59. PMid:22102928 PMCid:PMC3218540

16. Lumley J., Watson L., Watson M. et al. WITHDRAWN: periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects // Cochrane Database Syst. Rev. 2011. Vol. 4. ID CD001056.

17. Blencowe H., Cousens S., Modell B. et al. Folic acid to reduce neonatal mortality from neural tube disorders // Int. J. Epidemiol. 2010. Vol. 39. Suppl. 1. P. 110–121. https://doi.org/10.1093/ije/dyq028; PMid:20348114 PMCid:PMC2845867

18. Bentley S., Hermes A., Phillips D. et al. Comparative effectiveness of a prenatal medical food to prenatal vitamins on hemoglobin levels and adverse outcomes: a retrospective analysis // Clin. Ther. 2011. Vol. 33. № 2. P. 204–210. https://doi.org/10.1016/j.clinthera.2011.02.010; PMid:21440300

19. Van Beynum I.M., Kapusta L., Bakker M.K. et al. Protective effect of periconceptional folic acid supplements on the risk of congenital heart defects: a registry-based case-control study in the northern Netherlands // Eur. Heart J. 2010. Vol. 31. № 4. P. 464–471. https://doi.org/10.1093/eurheartj/ehp479; PMid:19952004

20. Czeizel A.E., Puho E.H., Langmar Z. et al. Possible association of folic acid supplementation during pregnancy with reduction of preterm birth: a population-based study // Eur. J. Obstet. Gynecol. Reprod. Biol. 2010. Vol. 148. № 2. P. 135–140. https://doi.org/10.1016/j.ejogrb.2009.10.016; PMid:19926391

21. Daly L.E., Kirke P.N., Molloy A. et al. Folate levels and neural tube defects: implications for prevention // JAMA. 1995. Vol. 274. № 21. P. 1698–1702. https://doi.org/10.1001/jama.1995.03530210052030; https://doi.org/10.1001/jama.274.21.1698

22. Fekete K., Berti C., Trovato M. et al. Effect of folate intake on health outcomes in pregnancy: a systematic review and meta-analysis on birth weight, placental weight and length of gestation // Nutr. J. 2012. Vol. 11. P. 75–86. https://doi.org/10.1186/1475-2891-11-75; PMid:22992251 PMCid:PMC3499376

23. Williams P.J., Bulmer J.N., Innes B.A. et al. Possible roles for folic acid in the regulation of trophoblast invasion and placental development in normal early human pregnancy // Biol. Reprod. 2011. Vol. 84. № 6. P. 1148–1153. https://doi.org/10.1095/biolreprod.110.088351; PMid:21349824

24. Salerno P., Bianchi F., Pierini A. et al. Folic acid and congenital malformation: scientific evidence and public health strategies // Ann. Ig. 2008. Vol. 20. № 6. P. 519–530. PMid:19238877

25. Kim M.W., Hong S.C., Choi J.S. et al. Homocysteine, folate and pregnancy outcomes // J. Obstet. Gynaecol. 2012. Vol. 32. № 6. P. 520–524. https://doi.org/10.3109/01443615.2012.693984; PMid:22779952

26. Bodnar L.M., Himes K.P., Venkataramanan R. et al. Maternal serum folate species in earlypregnancy and risk of preterm birth // Am. J. Clin. Nutr. 2010. Vol. 92. № 4. P. 864–871. https://doi.org/10.3945/ajcn.2010.29675; PMid:20739422 PMCid:PMC2937585

27. Bailey L.B., Berry R. Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage // Am. J. Clin. Nutr. 2005. Vol. 81. № 5. P. 1213–1217.

28. Puri M., Kaur L., Walia G.K. et al. MTHFR C677T polymorphism, folate, vitamin B12 and homocysteine in recurrent pregnancy losses: a case control study among North Indian women // J. Perinat. Med. 2013. Vol. 41. № 5. P. 549–554. https://doi.org/10.1515/jpm-2012-0252

29. Micle O., Muresan M., Antal L. et al. The influence of homocysteine and oxidative stress on pregnancy outcome // J. Med. Life. 2012. Vol. 5. № 1. P. 68–73. PMid:22574089 PMCid:PMC3307082

30. Takimoto H., Mito N., Umegaki K. et al. Relationship between dietary folate intakes, maternal plasma total homocysteine and B-vitamins during pregnancy and fetal growth in Japan // Eur. J. Nutr. 2007. Vol. 46. № 5. P. 300–306. https://doi.org/10.1007/s00394-007-0667-6; PMid:17623226

31. Szegedi S.S., Castro C.C., Koutmos M. et al. Betaine-homocysteine S-methyltransferase-2 is an S-methylmethionine-homocysteine methyltransferase // J. Biol. Chem. 2008. Vol. 283. № 14. P. 8939–8945. https://doi.org/10.1074/jbc.M710449200; PMid:18230605 PMCid:PMC2276374

32. Vollset S.E., Refsum H., Tverdal A. et al. Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study // Am. J. Clin. Nutr. 2001. Vol. 74. № 1. P. 130–136. PMid:11451728

33. Vollset S.E., Refsum H., Irgens L.M. et al. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study // Am. J. Clin. Nutr. 2000. Vol. 71. № 4. P. 962–968. https://doi.org/10.1097/00006254-200010000-00002

34. Xiao Y., Zhang Y., Wang M. et al. Plasma S-adenosylhomocysteine is associated with the risk of cardiovascular events in patients undergoing coronary angiography: a cohort study // Am. J. Clin. Nutr. 2013. Vol. 98. № 5. P. 1162–1169. https://doi.org/10.3945/ajcn.113.058727; PMid:24004894

35. Naess I.A., Christiansen S.C., Romundstad P.R. et al. Prospective study of homocysteine and MTHFR 677TT genotype and risk for venous thrombosis in a general population: results from the HUNT 2 study // Br. J. Haematol. 2008. Vol. 141. № 4. P. 529–535. https://doi.org/10.1111/j.1365-2141.2008.07073.x; PMid:18318759

36. Potter K. Homocysteine and cardiovascular disease: should we treat? // Clin. Biochem. Rev. 2008. Vol. 29. № 1. P. 27–30. PMid:18566666 PMCid:PMC2423315

37. Wong Y., Almenda O.P., McCaul K.A. et al. Homocysteine, frailty, and all-cause mortality in older men: the health in men study // J. Gerontol. A. Biol. Sci. Med. Sci. 2013. Vol. 68. № 5. P. 590–598. https://doi.org/10.1093/gerona/gls211; PMid:23070880

38. Virtanen J.K., Voutilainen S., Alfthan G. Homocysteine as a risk factor for CVD mortality in men with other CVD risk factors: the Kuopio Ischaemic Heart Disease Risk Factors (KIHD) Study // J. Intern. Med. 2005. Vol. 257. № 3. P. 255–262. https://doi.org/10.1111/j.1365-2796.2005.01450.x; PMid:15715682

39. Hogeveen M., Blom H.J., den Heijer M. Maternal homocysteine and small-for-gestational-age offspring: systematic review and meta-analysis // Am. J. Clin. Nutr. 2012. Vol. 95. № 1. P. 130–136. https://doi.org/10.3945/ajcn.111.016212; PMid:22170376

40. Timmermans S., Jaddoe V.W., Hofman A. et al. Periconception folic acid supplementation, fetal growth and the risks of low birth weight and preterm birth: the Generation R Study // Br. J. Nutr. 2009. Vol. 102. № 5. P. 777–785. https://doi.org/10.1017/S0007114509288994; PMid:19327193

41. Bukowski R., Malone F.D., Porter F.T. et al. Preconceptional folate supplementation and the risk of spontaneous preterm birth: a cohort study // PLoS Med. 2009. Vol. 6. № 5. ID 1000061.

42. Prinz-Langenohl R., Brдmswig S., Tobolski O. et al. (6S)-5-methyltetrahydrofolate increases plasma folate more effectively than folic acid in women with the homozygous or wild-type 677C>T polymorphism of methylenetetrahydrofolate reductase // Br. J. Pharmacol. 2009. Vol. 158. № 8. P. 2014–2021. https://doi.org/10.1111/j.1476-5381.2009.00492.x; PMid:19917061 PMCid:PMC2807663

43. Trabetti E. Homocysteine, MTHFR gene polymorphisms, and cardio-cerebrovascular risk // J. Appl. Genet. 2008. Vol. 49. № 3. P. 267–282. https://doi.org/10.1007/BF03195624; PMid:18670064

44. Morris M.S., Jacques P.F., Rosenberg I.H. et al. Circulating unmetabolized folic acid and 5-methyltetrahydrofolate in relation to anemia, macrocytosis, and cognitive test performance in American seniors // Am. J. Clin. Nutr. 2010. Vol. 91. № 6. P. 1733–1744. https://doi.org/10.3945/ajcn.2009.28671; PMid:20357042

45. Holm P.I., Hustad S., Ueland P.M. et al. Modulation of the homocysteine-betaine relationship by methylenetetrahydrofolate reductase 677 C->t genotypes and B-vitamin status in a large-scale epidemiological study // J. Clin. Endocrinol. Metab. 2007. Vol. 92. № 4. P. 1535–1541. https://doi.org/10.1210/jc.2006-1471; PMid:17284634

46. Громова О.А., Торшин И.Ю. Применение фолиевой кислоты в акушерско-гинекологической практике: методические рекомендации. М., 2010.

47. Kim Y.I. Folate and colorectal cancer: an evidence-based critical review // Mol. Nutr. Food Res. 2007. Vol. 51. № 3. P. 267–292. https://doi.org/10.1002/mnfr.200600191; PMid:17295418

48. Stolzenberg-Solomon R.Z., Chang S.C., Leitzmann M.F. et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial // Am. J. Clin. Nutr. 2006. Vol. 83. № 4. P. 895–904. PMid:16600944

49. Sauer J., Mason J.B., Choi S.W. Too much folate: a risk factor for cancer and cardiovascular disease? // Curr. Opin. Clin. Nutr. Metab. Care. 2009. Vol. 12. № 1. P. 30–36. https://doi.org/10.1097/MCO.0b013e32831cec62; PMid:19057184 PMCid:PMC2790187

50. Van Guelpen B. Folate in colorectal cancer, prostate cancer and cardiovascular disease // Scand. J. Clin. Lab. Invest. 2007. Vol. 67. № 5. P. 459–473. https://doi.org/10.1080/00365510601161513; PMid:17763182

51. Пустотина О.А., Орджоникидзе Н.В., Бутов Ю.С. Редкий случай токсикодермии у беременной // Акушерство и гинекология. 2002. № 3. С. 53–54.

52. Charles D., Ness A.R., Campbell D. et al. Taking folate in pregnancy and risk of maternal breast cancer // BMJ. 2004. Vol. 329. № 7479. P. 1375–1376. https://doi.org/10.1136/bmj.329.7479.1375; PMid:15591563 PMCid:PMC535452

53. Приказ Министерства здравоохранения РФ от 12 ноября 2012 г. № 572н «Об утверждении Порядка оказания медицинской помощи по профилю „акушерство и гинекология» (за исключением использования вспомогательных репродуктивных технологий“» // www.rosminzdrav.ru/documents/5828-prikaz-minzdrava-rossii-ot-12-noyabrya-2012g-572n.

54. Lamers Y., Prinz-Langenohl R., Brдmswig S. et al. Red blood cell folate concentrations increase more after supplementation with [6S]-5-methyltetrahydrofolate than with folic acid in women of childbearing age // Am. J. Clin. Nutr. 2006. Vol. 84. № 1. P. 156–161. PMid:16825690

55. Heit J.А., Kobbervig C.E., James A.H. et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study // Ann. Intern. Med. 2005. Vol. 143. № 10. P. 697–706.

56. Шехтман М.М. Руководство по экстрагенитальной патологии у беременных. 5-е изд. М.: Триада-Х, 2011.

Содержание журнала Текст статьи